Latest News in the pharma Industry

Biopharma News

Sartorius closes acquisition of selected assets of Danaher Life Sciences

Sartorius closes acquisition of selected assets of Danaher Life Sciences

4 May 2020

The addition of various laboratory and bioprocessing technologies will support customers to develop biotech medicines and vaccines.

Read more 
Moderna signs up Lonza to boost scale-up of mRNA vaccine for coronavirus

Moderna signs up Lonza to boost scale-up of mRNA vaccine for coronavirus

4 May 2020

Collaboration leverages CDMO’s expertise in tech transfer and manufacturing to aim for 1 million doses per day

Read more 
Scaling up and speeding up: pharma’s manufacturing challenges during COVID-19

Scaling up and speeding up: pharma’s manufacturing challenges during COVID-19

1 May 2020

As biopharma searches for vaccines and treatments to alleviate the crisis, how can companies manage shortened timelines to rapidly develop and manufacture safe and effective products on a global scale? A recent Endpoints webinar sheds some light

Read more 
Strides starts exports of generic version of Avigan for COVID-19 treatment

Strides starts exports of generic version of Avigan for COVID-19 treatment

29 Apr 2020

Antiviral drug has been developed in-house with API manufacturer signed up to secure KSM

Read more 
Merck KGaA to double viral vector capacity through EUR 100 million Carlsbad expansion

Merck KGaA to double viral vector capacity through EUR 100 million Carlsbad expansion

21 Apr 2020

Second 140,000 square-foot facility is expected to open next year

Read more 
How drug delivery and device manufacturers can capitalise on the biologics boom

How drug delivery and device manufacturers can capitalise on the biologics boom

17 Apr 2020

The biologics market is Pharma’s fastest growing market. With such significant growth of a different breed of products, what are the opportunities and implications for pharma packaging and drug delivery manufacturers?

Read more 
Nitrosamine contamination: pharma’s re-evaluation of its supply chain

Nitrosamine contamination: pharma’s re-evaluation of its supply chain

17 Apr 2020

The detection of nitrosamine impurities in some finished dosages has opened up a whole new set of challenges for API manufacturers who need to perform risk evaluations of their processes

Read more 
Fujifilm ramps up Avigan production as Japanese government stockpiles potential COVID-19 therapy

Fujifilm ramps up Avigan production as Japanese government stockpiles potential COVID-19 therapy

16 Apr 2020

Japanese drugmaker plans to meet 100,000 treatment course target by July

Read more 
Lupin receives FDA all-clear for Mandideep API manufacturing facility

Lupin receives FDA all-clear for Mandideep API manufacturing facility

15 Apr 2020

Company becomes the fourth Indian pharma firm to secure FDA clearance in the last two weeks

Read more 
Alfa Laval launches the first premium separator system for single-use biopharma processing

Alfa Laval launches the first premium separator system for single-use biopharma processing

14 Apr 2020

The CultureOne separator system uses product-contact parts that are replaceable and made from recyclable material.

Read more 
CDMO Cambrex completes biopharmaceutical expansion at Durham, NC facility

CDMO Cambrex completes biopharmaceutical expansion at Durham, NC facility

7 Apr 2020

Cambrex has completed an expansion of biopharmaceutical analysis capabilities at its Durham, North Carolina site, the contract development and manufacturing organisation said Tuesday.

Read more 
German pharma companies are meeting the corona stress test

German pharma companies are meeting the corona "stress test"

7 Apr 2020

The head of the leading German pharmaceutical industry organization says German firms are working top-speed to find coronavirus medications.

Read more